Elisabeth Scheer
Impact in
- Genetics top 2%
- Estrogen and related hormone effects
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics
- RNA Research and Splicing
- Retinoids in leukemia and cellular processes
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
Papers in
-
- Genomics and Chromatin Dynamics 21
- RNA Research and Splicing 15
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 5
- Protein Degradation and Inhibitors 5
- CRISPR and Genetic Engineering 3
- Microbial Metabolic Engineering and Bioproduction 2
- Pluripotent Stem Cells Research 2
- Urology 1
- Co-authors
- Làszlò ToraChristel BrouNicholas J. G. WebsterJohn H. WhitePierre ChambonDiane M. TassetCatherine Fromental-RamainIannis Talianidis
- Journals
- Molecular and Cellular Biology (5 papers)Journal of Biological Chemistry (4 papers)Nature Structural & Molecular Biology (2 papers)Nature Communications (2 papers)Molecular Cell (2 papers)
- Partner nations
- FranceUnited KingdomGermany
In The Last Decade
Elisabeth Scheer
30 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Genetics 1.1k
- Molecular Biology 2.0k
- Toxicology 58
- Oncology 299
- Endocrinology, Diabetes and Metabolism 180
Countries citing papers authored by Elisabeth Scheer
This map shows the geographic impact of Elisabeth Scheer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Scheer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Scheer more than expected).
Fields of papers citing papers by Elisabeth Scheer
This network shows the impact of papers produced by Elisabeth Scheer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Scheer. The network helps show where Elisabeth Scheer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisabeth Scheer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 18 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 10 | |
| 5 | 2021 | 3 | |
| 6 | 2018 | 37 | |
| 7 | 2017 | 19 | |
| 8 | 2016 | 86 | |
| 9 | 2015 | 40 | |
| 10 | 2015 | 70 | |
| 11 | 2013 | 115 | |
| 12 | 2012 | 23 | |
| 13 | 2012 | 76 | |
| 14 | 2007 | 46 | |
| 15 | 2005 | 44 | |
| 16 | 2004 | 214 | |
| 17 | 2003 | 50 | |
| 18 | 2002 | 75 | |
| 19 | 2001 | 57 | |
| 20 | 1993 | 69 |
About Elisabeth Scheer
Elisabeth Scheer is a scholar working on Molecular Biology, Urology, Cell Biology, Genetics and Analytical Chemistry, having authored 30 papers that have together received 2.5k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (21 papers), RNA Research and Splicing (15 papers), RNA modifications and cancer (11 papers), Epigenetics and DNA Methylation (5 papers), Protein Degradation and Inhibitors (5 papers), CRISPR and Genetic Engineering (3 papers), Microbial Metabolic Engineering and Bioproduction (2 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Genetics (1.1k citations), Molecular Biology (2.0k citations), Toxicology (58 citations), Oncology (299 citations) and Endocrinology, Diabetes and Metabolism (180 citations). Elisabeth Scheer has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Làszlò Tora, Christel Brou, Nicholas J. G. Webster, John H. White, Pierre Chambon, Diane M. Tasset, Catherine Fromental-Ramain, Iannis Talianidis, Adrien Staub and Imre Berger. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, Nature Structural & Molecular Biology, Nature Communications and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.